Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Diabetics Experience High Blood Sugar after Joint Surgery

By LabMedica International staff writers
Posted on 26 Mar 2019
People with diabetes who undergo joint replacement surgery are at sharply higher risk of experiencing elevated blood sugar after the operation, increasing their chances of developing infections and other complications.

Previous studies have shown that high blood sugar, or hyperglycemia, during the perioperative period of orthopedic joint replacement surgery is a risk factor for infection. More...
Patients requiring insulin can be considered to have more severe diabetes and have a greater chance of experiencing elevated blood glucose in the perioperative period.

Medical Scientists at the Hospital for Special Surgery (New York, NY, USA) reviewed the medical charts of 773 men and women who had undergone total hip or knee replacement between 2011 and 2016. Of those, 437 had been diagnosed with insulin-dependent diabetes, while 336 had not been diagnosed with the condition. It included patients with a diagnosis of diabetes whose blood sugar was being controlled using the hormone insulin and compared them to diabetics who did not require insulin.

The team reported that patients with insulin-dependent diabetes were more than five times as likely as those without the condition to develop hyperglycemia, or high blood sugar, after surgery (odds ratio, 5.2). Patients with higher blood glucose over the previous three months, as measured by glycated hemoglobin (HbA1c), were more likely to experience post-operative hyperglycemia regardless of which group they were in. An HbA1c above 6.59% for people with insulin-dependent diabetes, and 6.6% for those without the condition, was associated with an elevated risk for post-operative hyperglycemia.

Despite the increased risk for elevations in blood sugar after surgery, however, the incidence of post-operative joint infections did not differ between the two groups of patients. Bradford S. Waddell, MD, a hip and knee surgeon and co-author of the study noted that a limitation of the study was that it was underpowered to detect the risk of infection. He added, “If your patient comes in with diabetes and is dependent on insulin, you need to be more cognizant of controlling their blood sugar in the perioperative period because they're at higher risk.” The study was presented at the AAOS 2019 – the annual meeting of the American Academy of Orthopaedic Surgeons – held March 12-16, 2019, in Las Vegas, NV, USA.

Related Links:
Hospital for Special Surgery


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Multi-Chamber Washer-Disinfector
WD 390
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.